Stay updated on Lumateperone Adjunct in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Lumateperone Adjunct in Major Depressive Disorder Clinical Trial page.

Latest updates to the Lumateperone Adjunct in Major Depressive Disorder Clinical Trial page
- Check2 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the study details. The page displays the site header and a minimal error message, indicating access is blocked.SummaryDifference17%

- Check9 days agoChange DetectedA new publication citation was added under Publications, listing a study on sexual function with adjunctive lumateperone in patients with Major Depressive Disorder.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page revision label has been updated from v3.6.5 to v3.6.6, indicating a minor backend update to the study page.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a backend revision update for the study page. This change does not alter visible content or user-facing features.SummaryDifference0.0%

- Check58 days agoChange DetectedThe underlying software version was updated from v3.6.3 to v3.6.4, indicating a small backend patch.SummaryDifference0.0%

- Check65 days agoChange DetectedA Publications entry has been added listing the Earley et al. CNS Drugs article on safety and tolerability of adjunctive lumateperone in MDD, with PubMed as the source. A note indicates these publications are auto-filled from PubMed, expanding the study page with linked research references.SummaryDifference0.2%

Stay in the know with updates to Lumateperone Adjunct in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumateperone Adjunct in Major Depressive Disorder Clinical Trial page.